RELATED CONTENT
NEWS
- 4SC achieves hat trick of resminostat successes: RCC, CRC and now Hodgkin’s
- Bayer/Onyx's regorafenib looks positive in latest Phase III results for GIST
- Placebo patients to be offered Algeta's Alpharadin after efficacy in cancer trial
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

